Company Filing History:
Years Active: 2022-2024
Title: Greg Flynn - Innovator in Anti-Sclerostin Antibodies
Introduction
Greg Flynn is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-sclerostin antibodies. With a total of 2 patents, Flynn's work is paving the way for advancements in therapeutic treatments.
Latest Patents
Flynn's latest patents include innovative approaches to anti-sclerostin antibodies. The first patent focuses on C-terminal anti-sclerostin antibody variants, which generally relate to antibodies having C-terminal modifications and compositions comprising such antibodies. The second patent also addresses C-terminal antibody variants, emphasizing the same modifications and their potential applications.
Career Highlights
Greg Flynn is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Amgen has allowed him to collaborate with other talented professionals in the field, enhancing the impact of his inventions.
Collaborations
Some of Flynn's notable coworkers include Zhe Huang and Jennitte LeAnn Stevens. Their collaborative efforts contribute to the ongoing research and development of groundbreaking biotechnological solutions.
Conclusion
Greg Flynn's contributions to the field of anti-sclerostin antibodies exemplify the innovative spirit of modern biotechnology. His patents and work at Amgen Inc. highlight the importance of collaboration and creativity in advancing medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.